Cancer Systems Biology and Estrogen Receptors: Expert commentary by Robert Clarke

March 30, 2010

Oncology professor, Robert Clarke, discusses estrogen receptors, which are overexpressed in 70 percent of all breast cancer patients, and are the focus for much of the therapeutic research and drug discovery aimed at this disease. Yet, science knows relatively little about estrogen receptors, how they function normally, and how their malfunction contributes to cancer. Dr. Clarke explains how Georgetown’s new Center for Cancer Systems Biology plans to tease apart and map the molecular pathways in search of new targets against breast cancer.

Watch video at Georgetown University Webcasts.


Author: Georgetown University Communications